Analyst firms · Barclays · IQV

Barclays IQV price target and rating history

IQVIA Holdings Inc. (IQV) · Health Care

Barclays rates IQVIA Holdings Inc. (IQV) Overweight with a $210 price target, as of its latest action on Mar 6, 2026. It has published 4 rating actions on IQV since July 2021, including 1 upgrade and 1 downgrade. Across 5 firms with a IQV price target in the last 12 months, the median target is $213. Barclays's $210 is 1% below that.

Current rating
Overweight
Price target
$210
Median target, all firms
$213
Actions on IQV
4

Barclays price target on IQV

$287$229$17020222023202420252026
Barclays price target on IQV, each point a stated target, July 2021 to March 2026.

Every Barclays rating on IQV

How other firms rate IQV

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
UBSBuy$345Sep 30, 2026
Morgan StanleyEqual-Weight$200Jun 17, 2026
TD CowenBuy$213Mar 9, 2026
BarclaysOverweight$210Mar 6, 2026
RBC Capital MarketsOutperform$221Mar 3, 2026

Questions about Barclays and IQV

What is Barclays's price target for IQV?
Barclays's latest stated price target for IQVIA Holdings Inc. (IQV) is $210, from its action on Mar 6, 2026.
What is Barclays's rating on IQV?
Barclays rates IQV Overweight, a bullish rating, as of Mar 6, 2026.
When did Barclays last change its view on IQV?
On Mar 6, 2026, Barclays upgrades to Overweight from Equal Weight, price target $210.
How does Barclays's IQV target compare with other analysts?
Across 5 firms with a IQV price target in the last 12 months, the median target is $213. Barclays's $210 is 1% below that.

More IQV rating histories

All Barclays ratingsIQV news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.